AMETEK, Inc.

AMETEK entered FY2026 with a record backlog, underpinned by multi-year defense program commitments and growing aftermarket revenues. Revenue is not predominantly contractual or subscription-based, and the FY2020 COVID downturn produced approximately a 12% revenue decline, indicating above-average but not defensive predictability for an industrial instrument company.

The Electronic Instruments Group represents approximately 65-70% of consolidated revenue, with the Electromechanical Group providing the remainder, indicating meaningful segment concentration. End-market diversity within EIG, spanning process, aerospace, power, defense, and medical, partially offsets segment concentration as these businesses serve structurally uncorrelated demand cycles.

International revenue represented approximately 47% of consolidated net sales in FY2024, with U.S. operations at approximately 53%, Asia at roughly 21%, and meaningful European presence across the UK and continental markets. No single non-U.S. country approaches 25% of revenue, providing genuine multi-regional spread across North America, Europe, and Asia-Pacific.

Capital expenditure intensity runs approximately 2% of revenue ($160M projected for FY2026 against $7.4B in sales), low for an industrial manufacturer and reflective of the asset-light niche-instrument model. Operating income margins of approximately 25.6% (FY2024) have held across the FY2022-FY2025 period including through the inflationary cycle, demonstrating consistent structural operating leverage from a low-reinvestment business design.

Instruments and electromechanical devices are mission-critical components with low cost relative to total system value, reinforcing repeat-purchase dynamics from qualified customers. Aftermarket and service revenues add recurring layers, though the majority of sales remain transactional capital equipment orders rather than multi-year contractual subscriptions.